Reports
Reports
Sale
The global market for hypoglossal nerve stimulation therapy is expected to grow at a CAGR of about 13.2% in the forecast period of 2024-2032, owing to the rise in the prevalence of sleep disorders.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is expected to dominate the hypoglossal nerve stimulation therapy market in the forecast period. Major factors such as changes in lifestyle, rise in obstructive sleep apnea (OSA), high OSA-associated disease burden, favourable reimbursement policies, strong clinical pipeline, rising stress level, growing investments in the healthcare industry, and quick adoption of technology are expected to propel the market growth. Sleep disorders, especially sleep apnea, have emerged as a major public health concern in the United States. An estimated 22 million Americans suffer from sleep apnea, with 80 percent of moderate and severe obstructive sleep apnea cases going untreated . The low awareness regarding obstructive sleep apnea (OSA) and underdiagnosed cases represent a significant market development opportunity for the key players in the region.
Moreover, due to the high prevalence of sleep disorders in the United States, the government and non-government organisations are conducting campaigns to raise general awareness among people suffering from these disorders. This is likely to support the hypoglossal nerve stimulation therapy market in the country.
The hypoglossal nerve stimulator is a medical device that is implanted and electrically stimulates the hypoglossal nerve, causing tongue movement. This stimulation is timed to coincide with breathing in order to reduce upper airway blockage. The hypoglossal nerve stimulation system is totally implanted beneath the skin and is operated by a remote, allowing patients to sleep without thinking about devices on their face or in their mouth. Hypoglossal nerve stimulation (HGNS) is a novel technique for treating moderate to severe OSA in patients who cannot tolerate CPAP therapy.
The various treatment devices in the market are:
Based on product type, the market is divided into:
The several distribution channels of the market are:
The regional markets for hypoglossal nerve stimulation therapy can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing incidence of sleep deprivation disorders such as obstructive sleep apnea (OSA), a serious sleep disorder that increases the risk of fatal accidents or other health-related consequences caused by disrupted sleep, necessitates the global hypoglossal nerve stimulation therapy market. Hypoglossal neurostimulation devices are a relatively new, minimally sophisticated option and an innovative technique for treating obstructive sleep apnea. These devices aid in restoring the tone of the upper airway dilator muscle, hence reducing airway blockage. These devices are anticipated to provide lucrative opportunities to the market over the forecast period.
Further, the increase in chronic diseases, rise in geriatric population, growing research and development activities, along with technological advancements such as miniaturisation and automation, among others, are positively influencing the growth of the market during the forecast period. Favourable reimbursement scenarios related to implantation procedures in these facilities will further drive the market growth globally. Rising focus on operational efficiency, short stay, and highly efficient healthcare professionals will foster the market revenue. Other factors expected to fuel the market expansion during the forecast period include increasing healthcare expenditure, increasing awareness of the disorder and accessible treatment choices, which will lead to early diagnosis.
The report gives a detailed analysis of the following key players in the global hypoglossal nerve stimulation therapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment Devices |
|
Breakup by Product Type |
|
Breakup by Distribution Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Hypoglossal Nerve Stimulation Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Hypoglossal Nerve Stimulation Therapy Historical Market (2017-2023)
8.3 Global Hypoglossal Nerve Stimulation Therapy Market Forecast (2024-2032)
8.4 Global Hypoglossal Nerve Stimulation Therapy Market by Treatment Devices
8.4.1 Aura 6000 Sleep Therapy System
8.4.1.1 Historical Trend (2017-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Inspire II Upper Airway Stimulation Device
8.4.2.1 Historical Trend (2017-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Others
8.5 Global Hypoglossal Nerve Stimulation Therapy Market by Product Type
8.5.1 Battery Free
8.5.1.1 Historical Trend (2017-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Leadless
8.5.2.1 Historical Trend (2017-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Implantable
8.5.3.1 Historical Trend (2017-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Electrodes
8.5.4.1 Historical Trend (2017-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Others
8.6 Global Hypoglossal Nerve Stimulation Therapy Market by Distribution Channel
8.6.1 Hypermarkets and Supermarkets
8.6.1.1 Historical Trend (2017-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmacies and Drug Stores
8.6.2.1 Historical Trend (2017-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Online
8.6.3.1 Historical Trend (2017-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Hypoglossal Nerve Stimulation Therapy Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2017-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2017-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2017-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2017-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2017-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Hypoglossal Nerve Stimulation Therapy Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2017-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2017-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Hypoglossal Nerve Stimulation Therapy Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2017-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2017-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2017-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2017-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Hypoglossal Nerve Stimulation Therapy Market Analysis
11.1 China
11.1.1 Historical Trend (2017-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2017-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2017-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2017-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2017-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Hypoglossal Nerve Stimulation Therapy Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2017-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2017-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2017-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Hypoglossal Nerve Stimulation Therapy Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2017-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2017-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2017-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2017-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Nyxoah SA.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Fisher & Paykel Healthcare Limited
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Invacare Corporation
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Braebon Medical Corporation
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Hypoglossal Nerve Stimulation Therapy Market: Key Industry Highlights, 2017 and 2032
2. Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Treatment Devices (USD Million), 2017-2023
3. Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Treatment Devices (USD Million), 2024-2032
4. Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Product Type (USD Million), 2017-2023
5. Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Product Type (USD Million), 2024-2032
6. Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Distribution Channel (USD Million), 2017-2023
7. Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
8. Global Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Region (USD Million), 2017-2023
9. Global Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2017-2023
11. North America Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2017-2023
13. Europe Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2017-2023
15. Asia Pacific Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2017-2023
17. Latin America Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Hypoglossal Nerve Stimulation Therapy Historical Market: Breakup by Country (USD Million), 2017-2023
19. Middle East and Africa Hypoglossal Nerve Stimulation Therapy Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Hypoglossal Nerve Stimulation Therapy Market Structure
The global market for hypoglossal nerve stimulation therapy is projected to grow at a CAGR of 13.2% between 2024 and 2032.
The major drivers of the market include the increase in chronic diseases, rise in geriatric population, growing research and development activities, technological advancements, favourable reimbursement scenarios, and increasing healthcare expenditure.
The growing incidence of sleep deprivation disorders such as obstructive sleep apnea and increasing awareness of the disorder are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The various treatment devices in the market are aura 6000 sleep therapy system and inspire II upper airway stimulation device, among others.
Based on product type, the market is divided into battery free, leadless, implantable, and electrodes, among others.
The several distribution channels of the market are hypermarkets and supermarkets, pharmacies and drug stores, and online, among others.
The major players in the industry are Nyxoah SA., Fisher & Paykel Healthcare Limited, Invacare Corporation, Braebon Medical Corporation, and Oventus Medical USA, Inc., among others.
The global hypoglossal nerve stimulation therapy market was driven by the growing incidence of sleep deprivation disorders, such as obstructive sleep apnea, in the historical period. Aided by the favourable reimbursement scenarios and increasing awareness of the disorder, the market is expected to grow at a CAGR of 13.2% in the forecast period of 2024-2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The various treatment devices in the market are aura 6000 sleep therapy system and inspire II upper airway stimulation device, among others. Based on product type, the market is divided into battery free, leadless, implantable, and electrodes, among others. The several distribution channels of the market are hypermarkets and supermarkets, pharmacies and drug stores, and online, among others. The major regional markets for hypoglossal nerve stimulation therapy are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the above market are Nyxoah SA., Fisher & Paykel Healthcare Limited, Invacare Corporation, Braebon Medical Corporation, and Oventus Medical USA, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.